Comparison of GERD Incidence Rates Based on GERD-Q in Chronic Hepatitis and Decompensated Liver Cirrhosis Patients

This research investigates the incidence of Gastroesophageal Reflux Disease (GERD) in patients with chronic hepatitis and decompensated liver cirrhosis, using the GERD-Q questionnaire as a diagnostic tool. The study aims to compare the prevalence of GERD symptoms in these two liver disease groups and explore the potential impact of GERD on patient management and health outcomes. Data were collected from a cohort of patients diagnosed with chronic hepatitis and decompensated liver cirrhosis, who completed the GERD-Q questionnaire to assess their symptoms. The findings reveal a significantly higher incidence of GERD in patients with decompensated liver cirrhosis compared to those with chronic hepatitis. Furthermore, the study highlights the importance of early detection and treatment of GERD in hepatic patients to prevent complications such as esophagitis and variceal bleeding, which are associated with poor prognosis in liver disease. By identifying the symptom burden in these populations, the research underscores the need for tailored treatment strategies, including pharmacological interventions and lifestyle modifications, to optimize management and improve patient outcomes. This study provides valuable insights into the relationship between GERD and liver disease, offering guidance for clinicians in managing gastrointestinal symptoms in hepatic patients.